Диссертация (1174275), страница 26
Текст из файла (страница 26)
- №283. – Р.1429–1436.15789. Barnett H.J. The inappropriate use of carotid endarterectomy/ H.J. Barnett//CMAJ. -2004. - №171(5). – Р.473–474.90. Bluth E.I. Sonographic characterization of carotid plaque: Detection ofhemorrhage/ E.I. Bluth, D.
Kay, C.R. Merritt, et al.// Am J Roentgenol. – 1986.- №146. – Р.1061–1065.91. Boekhoven R.W. A novel experimental approach for three-dimensionalgeometry assessment of calcified human stenotic arteries in vitro/ R.W.Boekhoven, R.G.P. Lopata, M.R. van Sambeek, et al.// Ultrasound Med Biol. –2013. - №39. – Р.1875–1886.92. Bogiatzi C. Identifying highrisk asymptomatic carotids stenosis/ C.
Bogiatzi,M.S. Cocker, R. Beanlands, J.D. Spence// Expert Opin Med Diagn. – 2012. №6(2). – Р.139–151.93. Bogiatzi C. Secular trends in ischemic stroke subtypes and stroke risk factors/C. Bogiatzi, D.G. Hackam, A.I. McLeod, J.D. Spence// Stroke. – 2014. №45(11). – Р.3208–3213.94. Bonati L.H. for the International Carotid Stenting Study Investigators. Longterm outcomes after stenting versus endarterectomy for treatment ofsymptomatic carotid stenosis: the International Carotid Stenting Study (ICSS)randomised trial/ L.H.
Bonati, J. Dobson, R.L. Featherstone et al.// Lancet. –2015. - №385. – Р.529-538.95. Bonati L.H. on behalf of the CAVATAS Investigators. Longterm risk ofcarotid restenosis in patients randomly assigned to endovascular treatment orendarterectomy in the Carotid and Vertebral Artery Transluminal AngioplastyStudy (CAVATAS): long-term follow-up of a randomised trial/ L.H. Bonati, J.Ederle, D.J.H. McCabe et al.// Lancet Neurol. – 2009.- №8. – Р.908-917.96. Brott T.G. Stenting versus endarterectomy for treatment of carotid-arterystenosis/ T.G. Brott, R.W.
Hobson II, G. Howard, et al.// N Engl J Med. –2010. - №363(1). – Р.11–23.15897. Brown M.M. Should sex influence the choice between carotid stenting andcarotid endarterectomy?/ M.M. Brown, R. Raine// Lancet Neurol. – 2011. №10(6). – Р.494–497.98. Gent M. CAPRIE Steering Committee. A randomised, blinded, trial ofclopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)/ M.Gent, D.
Beaumont, J. Blanchard et al.// Lancet. – 1996. - №348(9038).Р.1329-1339.99. Chamorro A. Ex vivo response to aspirin differs in stroke patients with singleor recurrent events: A pilot study/ A. Chamorro, G. Escolar, M. Revilla, et al.//J Neurol Sci. – 1999. - №171. – Р.110–114.100. Chaturvedi S. Large artery atherosclerosis: carotid stenosis, vertebral arterydisease, and intracranial atherosclerosis. Continuum (Minneapolis, Minn)/ S.Chaturvedi, P.
Bhattacharya// Cerebrovasc Dis. – 2014. - №20. – Р.323–334.101. Chaturvedi S. Aggressive medical therapy alone is adequate in certain patientswith severe symptomatic carotid stenosis/ S. Chaturvedi// Stroke. – 2013.№44(10). – Р.2957–2958.102. Chimowitz M.I. Stenting versus aggressive medical therapy for intracranialarterial stenosis/ M.I. Chimowitz, M.J. Lynn, C.P. Derdeyn et al.// N Engl JMed. -2011.
- №365(11). – Р.993–1003.103. Chimowitz M.I. SAMMPRIS Trial Investigators. Stenting versus aggressivemedical therapy for intracranial arterial stenosis/ M.I. Chimowitz, M.J. Lynn,C.P. Derdeyn et al.// N Engl J Med. – 2011. - №365(11). – Р.993-1003.104. Chimowitz M.I. Cardiac prognosis of patients with carotid stenosis and nohistory of coronary artery disease. Veterans Affairs Cooperative Study Group167/ M.I.
Chimowitz, D.G. Weiss, S.L. Cohen et al.// Stroke. – 1994. №25(4). – Р.759–765.105. Clarke S.E. Quantitative assessment of carotid plaque composition usingmulticontrast MRI and registered histology/ S.E. Clarke, R.R. Hammond, J.R.Mitchell, B.K. Rutt// Magn Reson Med.
– 2003. - №50(6). – Р.1199–1208.159106. Cocker M.S. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucosepositron emission tomography/computed tomography imaging: what Leonardoda Vinci could not see/ M.S. Cocker, A.B. Mc, J.D. Spence et al.// J NuclCardiol. – 2012. - №19(6). – Р.1211–1225.107. De Borst G.J. Biology and treatment of recurrent carotid stenosis/ G.J.
DeBorst, F. Moll// J Cardiovasc Surg (Torino). – 2012. - №53(1 Suppl.). – Р.2734.108. de Weerd M. Prevalence of asymptomatic carotid artery stenosis in the generalpopulation: an individual participant data meta-analysis/ M. de Weerd, J.P.Greving, B. Hedblad et al.// Stroke. – 2010. - №41. – Р.1294–1297.109. Diener H.C. European Stroke Prevention Study 2. Dipyridamole andacetylsalicylic acid in the secondary prevention of stroke/ H.C.
Diener, L.Cunha, C. Forbes et al.// J. Neurol. Sci. - 1996. - Vol.143. - №1–2. - P.1–13.110. Eckstein H.H. Results of the Stent-Protected Angioplasty versus CarotidEndarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: amultinational, prospective, randomized trial/ H.H. Eckstein, P. Ringleb, J.R.Allenberg et al.// Lancet Neurol. – 2008. - №7. – Р.893-902.111. Edwards A.
Evaluation of the INNOVANCE PFA P2Y test cartridge:Sensitivity to P2Y blockade and influence of anticoagulant/ A. Edwards, J.A.Jakubowski, A.R. Rechner et al.// Platelets. – 2012. - №23. - Р.106–115.112. Flaherty M.L. Carotid artery stenosis as a cause of stroke/ M.L. Flaherty, B.Kissela, J.C. Khoury et al.// Neuroepidemiology. – 2013. - №40.- Р.36–41.113. Fong J. Predictors of biochemical aspirin and clopidogrel resistance in patientswith ischemic stroke/ J. Fong, E.
Cheng-Ching, M.S. Hussain et al.// J StrokeCerebrovasc Dis. – 2011. - №20. – Р.227–230.114. Fosse E. Repeated visual and computer-assisted carotid plaque characterizationin a longitudinal population-based ultrasound study: The Tromsø study/ E.Fosse, S.H. Johnsen, E. Stensland-Bugge et al.// Ultrasound Med Biol. – 2006.- №32.- Р.3–11.160115. Gengo F.M.
Prevalence of platelet nonresponsiveness to aspirin in patientstreated for secondary stroke prophylaxis and in patients with recurrent ischemicevents/ F.M. Gengo, M. Rainka, M. Robson et al.// J Clin Pharmacol. – 2008. №48. – Р.335–343.116. Geraghty P.J. Preoperative symptom type influences the 30-day perioperativeoutcomes of carotid endarterectomy and carotid stenting in the Society forVascular Surgery Vascular Registry/ P.J.
Geraghty, T.E. Brothers, D.L.Gillespie et al.// J Vasc Surg. -2014. - №60(3). – Р.639–644.117. Goff S.L. How cardiologists present the benefits of percutaneous coronaryinterventions to patients with stable angina: a qualitative analysis/ S.L. Goff,K.M. Mazor, H.H. Ting et al.// JAMA InternMed. – 2014. - №174(10). –Р.1614–1621.118. Goldstein L.B. Guidelines for the primary prevention of stroke: a guideline forhealthcare professionals from the American Heart Association/AmericanStroke Association/ L.B.
Goldstein, C.D. Bushnell, R.J. Adams et al.// Stroke.– 2011. - №42. – Р.517-584.119. Grau A.J. Platelet function under aspirin, clopidogrel, and both after ischemicstroke: A casecrossover study/ A.J. Grau, S. Reiners, C. Lichy et al.// Stroke. –2003. - №34. – Р.849–854.120. Gray-Weale A.C. Carotid artery atheroma: Comparison of preoperative Bmode ultrasound appearance with carotid endarterectomy specimen pathology/A.C.
Gray-Weale, J.C. Graham, J.R. Burnett et al.// J Cardiovasc Surg(Torino). – 1988. - №29. – Р.676–681.121. Grønholdt M.L. Spiral computed tomographic imaging related to computerizedultrasonographic images of carotid plaque morphology and histology/ M.L.Grønholdt, A. Wagner, B.M. Wiebe et al.// J Ultrasound Med.
– 2001. - №20. –Р.451–458.122. Grosser T. Drug resistance and pseudoresistance: an unintended consequenceof enteric coating aspirin/ T. Grosser, S. Fries, J.A. Lawson et al.// Circulation.– 2013. - №127(3). – Р. 377-385.161123. Gum P. Profile and prevalence of aspirin resistance in patients withcardiovascular disease/ P. Gum, E. Topol, E.D. Poggio et al.// Am. J.Cardiol.
–2001. - №88(3). – Р.230.124. Gurney D. Platelet function testing: from routine to specialist testing/ D.Gurney// Br J Biomed Sci. – 2016. - №73(1).- Р.10-20.125. Hackam D.G. Combining multiple approaches for the secondary prevention ofvascular events after stroke: a quantitative modelling study/ D.G. Hackam, J.D.Spence// Stroke. – 2007.
- №38(6). – Р.1881-1885.126. Halliday A. Prevention of disabling and fatal strokes by successful carotidendarterectomy in patients without recent neurological symptoms: randomisedcontrolled trial/ A. Halliday, A. Mansfield, J. Marro, et al.// Lancet. – 2004. №363(9420). –Р.1491–1502.127. Hankey G.J. Aspirin resistance/ G.J. Hankey, J.W.
Eikelboom // The Lancet. –2006. - №367(9510). - Р.606–617.128. Harrison P. Screening for aspirin responsiveness after transient ischemic attackand stroke: Comparison of 2 point-of-care platelet function tests with opticalaggregometry/ P. Harrison, H. Segal, K. Blasbery et al.// Stroke. – 2005. №36.- Р.1001–1005.129. Harrison P. Lack of reproducibility of assessment of aspirin responsiveness byoptical aggregometry and two platelet function tests/ P.
Harrison, H. Segal, L.Silver et al.// Platelets. – 2008. - №19. - Р.119–124.130. Helgason C.M. Development of aspirin resistance in persons with previousischemic stroke/ C.M. Helgason, K.M. Bolin, J.A. Hoff et al.// Stroke. – 1994. №25. – Р.2331–2336.131. Helgason C.M. Aspirin response and failure in cerebral infarction/ C.M.Helgason, K.L. Tortorice, S.R. Winkler et al.// Stroke. – 1993. - №24.- Р.345–350.132.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
